Thomas Christély
Chief Executive Officer at Atugen AG
Profile
Thomas Christély is currently the Chief Executive Officer at Metriopharm AG and Atugen AG.
He previously worked as the Chief Executive Officer at Silence Therapeutics Plc, Managing Director & Chief Financial Officer at MYR GmbH, Principal at Arthur Andersen LLP, and Chief Financial Officer & Senior Vice President at Nuvo Research AG.
He also worked as the Managing Partner at Löschen & Partner GmbH.
Christély received his undergraduate and graduate degrees from the University of Hamburg.
Thomas Christély active positions
| Companies | Position | Start |
|---|---|---|
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Chief Executive Officer | 2000-12-31 |
Metriopharm AG
 Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | Chief Executive Officer | 2021-09-30 |
Former positions of Thomas Christély
| Companies | Position | End |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Chief Executive Officer | 2012-02-09 |
Nuvo Research AG
 Nuvo Research AG Pharmaceuticals: MajorHealth Technology Part of Searchlight Pharma, Inc., Nuvo Research AG is a Swiss pharmaceutical manufacturing company. The company is based in Fribourg, Switzerland. | Director of Finance/CFO | 1999-12-31 |
MYR GmbH
 MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany. | Chief Executive Officer | - |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Corporate Officer/Principal | - |
Training of Thomas Christély
| University of Hamburg | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Private companies | 5 |
|---|---|
Metriopharm AG
Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | Health Technology |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
Nuvo Research AG
Nuvo Research AG Pharmaceuticals: MajorHealth Technology Part of Searchlight Pharma, Inc., Nuvo Research AG is a Swiss pharmaceutical manufacturing company. The company is based in Fribourg, Switzerland. | Health Technology |
Atugen AG
Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Health Technology |
MYR GmbH
MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany. | Health Technology |
- Stock Market
- Insiders
- Thomas Christély
